Advertisement

Topics

Allergy Therapeutics Company Profile

08:22 EST 19th January 2019 | BioPortfolio

Allergy Therapeutics®. (AT) is a Europe-based specialty pharmaceutical company focused upon the treatment and prevention of allergy. AT has an existing sales base of approximately £19m/€27m per annum, an MHRA-approved manufacturing capability and an established sales and marketing infrastructure in several major European markets. In addition, the Company has a number of novel compounds which have already undergone initial clinical evaluation and once registered could potentially revolutionise the treatment of allergy. An established range of specific immunotherapy diagnostics and therapies, generating growing revenues of approximately £19m/€27m per annum.
Certain exclusive rights to MPL®, a novel immunological adjuvant in the field of allergy, licensed from Corixa Corporation.
An innovative product development pipeline supported by documented clinical evidence of efficacy and safety.
Intellectual property rights to five patent families with further rights to the use of MPL® in new formulations. Patent protection for new products extends to the years 2018-20.
A highly qualified scientific and commercial team with industry experienced management.
A European sales and marketing team in Germany, Italy and Spain.
High quality facilities, including cGMP manufacturing, capable of increased production capacity.

Location

Dominion Way
Worthing
West Sussex
BN14 8SA
United Kingdom

Contact

Phone: 44 1903 844700
Fax: 44 1903 844744
Email: infoservices@allergytherapeutics.com


News Articles [1072 Associated News Articles listed on BioPortfolio]

DGAP-News: Allergy Therapeutics plc berichtet vorläufige Ergebnisse für das zum 30. Juni 2018 endende Geschäftsjahr (deutsch)

Allergy Therapeutics plc berichtet vorläufige Ergebnisse für das zum 30. Juni 2018 endende Geschäftsjahr DGAP-News: Allergy Therapeutics plc / Schlagwort(e): Jahresergebnis Allergy Therapeutics pl....

DGAP-News: Allergy Therapeutics gibt Ergebnisse der Hauptversammlung 2018 bekannt (deutsch)

Allergy Therapeutics gibt Ergebnisse der Hauptversammlung 2018 bekannt DGAP-News: Allergy Therapeutics plc / Schlagwort(e): Hauptversammlung Allergy Therapeutics gibt Ergebnisse der Hauptversammlun...

Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers

Sunnyvale, Aug. 27, 2018 (GLOBE NEWSWIRE) -- August 27, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces allergy testing partne...

DGAP-News: Allergy Therapeutics gibt Veränderungen im Board of Directors bekannt (deutsch)

Allergy Therapeutics gibt Veränderungen im Board of Directors bekannt DGAP-News: Allergy Therapeutics plc / Schlagwort(e): Personalie Allergy Therapeutics gibt Veränderungen im Board of Directors b....

DGAP-News: Allergy Therapeutics plc: Allergy Therapeutics gibt Update zur Geschäftsentwicklung und Publikationstermin des vorläufigen Halbjahresergebnis für das 2018/2019 bekannt (deutsch)

Allergy Therapeutics gibt Update zur Geschäftsentwicklung und Publikationstermin des vorläufigen Halbjahresergebnis für das Geschäftsjahr 2018/2019 bekannt DGAP-News: Allergy Therapeutics plc / Sc...

Aimmune Therapeutics' Peanut Allergy Immunotherapy Looks Promising in Phase III Trial

It is estimated that 2.5 percent of all children in the U.S. might have a peanut allergy. Since 2010, according to the America College of Allergy, Asthma and Immunology, incidence of peanut allergies ...

Allergy Therapeutics says revenues “up strongly on prior year” in update ahead of AGM

The firm, which specialises in allergy vaccines, said sales were in line with expectations for the year, adding that it had continued to gain market share in Europe

Global Allergy Immunotherapy Market (2018-2022) featuring Allergy Therapeutics, ALK-Abello, ...

ResearchAndMarkets.comLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call ...

PubMed Articles [1406 Associated PubMed Articles listed on BioPortfolio]

Modulating the Microbiome: The Future of Allergy Therapeutics?

A Retrospective Critical Analysis and Risk Stratification of Penicillin Allergy De-labelling in a UK Specialist Regional Allergy Service.

A spurious label of penicillin allergy (Pen-A) negatively impacts on antibiotic stewardship and healthcare costs. Recent studies have proposed a guideline-steered direct penicillin challenge without u...

Recent advances in the management of allergy associated diseases in children.

The allergy symptoms could arise from variable organ systems and have fluctuating nature in severity as well as symptoms. Moreover, these symptoms could be related to multiple pathological states like...

Who needs penicillin allergy testing?

All individuals with an unconfirmed penicillin allergy should have their penicillin allergy evaluated, and if appropriate, tested to confirm current hypersensitivity or tolerance.

Parent Experiences with Paediatric Allergy Pathways in the West Midlands: A Qualitative study.

The prevalence, severity and complexity of allergic diseases has been increasing steadily in the UK over the last few decades. Primary care physicians are often not adequately trained in allergy manag...

Clinical Trials [675 Associated Clinical Trials listed on BioPortfolio]

De-labeling of Patients With False Diagnosis of Penicillin Allergy

The purpose of this study is to estimate the prevalence of penicillin allergy, evaluate the diagnostic value of the allergologic work-up used in the study, and the health effects of penici...

The Influence of Early and Continuous Exposure of Infants to Cow's Milk Formula on the Prevention of Milk Allergy

Cow's milk protein (CMP) allergy is one of the most common food allergies and potentially a fatal one. Early feeding with CMP has been considered in the past as a risk factor for developme...

Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

The purpose of this research study is to find out if cat allergy shots with combination with AMG 157, an experimental medication, will help the cat allergy shots work after just one year o...

Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects

Cat allergy is an increasingly prevalent condition, affecting 10-15% of patients with allergic rhinoconjunctivitis and/or asthma. Cat-PAD is a novel, synthetic, allergen-derived peptide d...

Sublingual Milk Immunotherapy in Children

Sublingual immunotherapy is developing in the treatment of aeroallergens allergy. The hypothesis is that such process may be applied to food allergy, more precisely to milk. A previous se...

Companies [1446 Associated Companies listed on BioPortfolio]

Allergy Cure

Allergies like food allergies i.e. Peanut allergy wheat allergy milk allergy dog allergies cat allergies latex allergy skin allergies dust mites allergy cure by Aller-X herbal Medicine admark herba...

Prota Therapeutics Pty Ltd

Prota Therapeutics is a newly established Australian private company developing immunotherapy based treatments for food allergy. The company’s lead product based on innovativ...

HAL Allergy Group

The HAL Allergy Group (http://www.hal-allergy.com) was established in 1959 and is a main European manufacturer of allergy vaccines and diagnostics. The Group's products are distributed via subsidi...

Planet Technologies

On March 9, 2005, Planet announced a definitive agreement to acquire privately-owned Allergy Control Products. The combination of Planet’s Allergy Free business with Allergy Control will create one ...

Allergy Therapeutics

Allergy Therapeutics®. (AT) is a Europe-based specialty pharmaceutical company focused upon the treatment and prevention of allergy. AT has an existing sales base of approximately £19m/€27m per an...

More Information about "Allergy Therapeutics" on BioPortfolio

We have published hundreds of Allergy Therapeutics news stories on BioPortfolio along with dozens of Allergy Therapeutics Clinical Trials and PubMed Articles about Allergy Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Allergy Therapeutics Companies in our database. You can also find out about relevant Allergy Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record